| Alternative NSN: 6505-01-656-4667 |
| Item Name: Fentanyl Transdermal System |
| NIIN: 016564667 |
| NCB Code: USA (01) |
| Manufacturers: Actavis Pharma Inc, Janssen Pharmaceuticals Inc, Mallinckrodt Inc, Mylan Pharmaceuticals Inc, Par Pharmaceutical Inc, Sandoz Inc |
Browse NSN parts of NSN 6505-01-656-4667 and get lowest price for your requested parts in 15 minutes. Just ordered part of NSN 6505-01-656-4667 like NDC50458-0093-05, NDC49884-0763-78, NDC00781-7243-55, NDC00591-3213-72, NDC00406-9075-76 described as Fentanyl Transdermal System from industry leading manufactures such as Janssen Pharmaceuticals Inc, Par Pharmaceutical Inc, Sandoz Inc, Actavis Pharma Inc, Mallinckrodt Inc. We are proud to offer an inventory of over 2 billion ready-to-ship parts, 24/7 availability, and key locations in the U.S./abroad. These attributes allow us to meet all aircraft on ground (AOG) requirements with ease.
| Part No | Manufacturer | Item Name | QTY | RFQ |
|---|---|---|---|---|
| NDC50458-0093-05 | Janssen Pharmaceuticals Inc | fentanyl transdermal system | Avl | RFQ |
| NDC49884-0763-78 | Par Pharmaceutical Inc | fentanyl transdermal system | Avl | RFQ |
| NDC00781-7243-55 | Sandoz Inc | fentanyl transdermal system | Avl | RFQ |
| NDC00591-3213-72 | Actavis Pharma Inc | fentanyl transdermal system | Avl | RFQ |
| NDC00406-9075-76 | Mallinckrodt Inc | fentanyl transdermal system | Avl | RFQ |
| NDC00378-9123-98 | Mylan Pharmaceuticals Inc | fentanyl transdermal system | Avl | RFQ |
| MRC | Criteria | Characteristic |
|---|---|---|
| FEAT | Special Features | ROUTE: TRANSDERMAL; DOSE FORM: PATCH, TRANSDERMAL 72 HOURS; STRENGTH: 75 MCG/HOUR; DEA CONTROLLED II SUBSTANCE; INDIVIDUALLY SEALED; CONTAINS FIVE (75 MCG/HR) TRANSDERMAL SYSTEMS; STORE IN ORIGINAL UNOPENED POUCH. STORE UP TO 20 C TO 25 C (68 F TO 77 F; STRICT ADHERENCE TO THE RECOMMENDED HANDLING AND DISPOSAL INSTRUCTIONS ON PRODUCT INSERT IS OF THE UTMOST IMPORTANCE TO PREVENT ACCIDENTAL EXPOSURE; EXPOSURE OF FENTANYL TRANSDERMAL SYSTEM APPLICATION SITE AND SURROUNDING AREA TO DIRECT EXTERNAL HEAT SOURCES, SUCH AS HEATING PADS, SAUNAS, HOT TUBS AND HEATED WATER BEDS MAY INCREASE FENTANYL ABSORPTION AND RESULT IN FATAL OVERDOSE OF FENTANYL AND DEATH; PATIENTS WHO DEVELOP FEVER OR INCREASED CORE BODY TEMPERATURE DUE TO STRENOUS EXERTION ARE ALSO AT RISK FOR INCREASED FENTANYL EXPOSURE AND MAY REQUIRE AN ADJUSTMENT IN THE DOSE OF FENTANYL TRANSDERMAL SYSTEM TO AVOID OVERDOSE |
| CSLZ | Usual Dose | 75 MCG/HR |
| CBBL | Features Provided | INDIVIDUALLY SEALED |
| CRYC | Controlled Substance Classification | SCHEDULE II |
| CXCY | Part Name Assigned By Controlling Agency | DURAGESIC-75 (FENTANYL TRANSDERMAL SYSTEM) 75MCG/HR, 5S |
| MRC | Decoded Requirement | Clear Text Reply |
|
6505-00-004-6658 (6505000046658) |
6505-00-004-6666 (6505000046666) |
6505-00-004-6676 (6505000046676) |
|
6505-00-005-3940 (6505000053940) |
6505-00-006-3321 (6505000063321) |
6505-00-007-2156 (6505000072156) |
|
6505-00-007-4529 (6505000074529) |
6505-00-007-4531 (6505000074531) |
6505-00-007-4535 (6505000074535) |
|
6505-00-007-4538 (6505000074538) |
6505-00-007-8290 (6505000078290) |
6505-00-007-8293 (6505000078293) |
Before You Go, Why Don’t You Take a Look at Our Aviation Parts Catalog.
Request for Quote